Medigus Ltd logo

Medigus Ltd (MDGS)

Delisted
17 Apr 2024
NASDAQ (CM) NASDAQ (CM)
$
2. 36
+0.22
+10.2804%
$
4.47M Market Cap
- P/E Ratio
- Div Yield
25,629 Volume
0 Eps
$ 2.14
Previous Close
Day Range
2.17 2.58
Year Range
1.54 7.17
Want to track MDGS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

MDGS Chart

Medigus Ltd (MDGS) FAQ

What does "Delisted" mean?

Medigus Ltd has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

The last recorded dividend was paid on Dec 19, 2022 in the amount of $0.85 per share.

How long did the company pay dividends?

The company did not have a dividend payment history.

Were there any stock splits?

The last recorded stock split occurred on Aug 05, 2024 with a ratio of 3:8.

What was the last known trading price?

The stock last traded at $2.36 on Apr 17, 2024 before being delisted.

Medigus Ltd Profile

Technology Hardware, Storage & Peripherals Industry
Information Technology Sector
Liron Carmel CEO
NASDAQ (CM) Exchange
58471G201 CUSIP
IL Country
38 Employees
28 Dec 2022 Last Dividend
5 Aug 2024 Last Split
5 Aug 2015 IPO Date

Overview

Medigus Ltd. is a technology-centered company that specializes in developing medical devices and products, offering innovative solutions across a broad range of applications. Founded in 1999 and based in Tel Aviv-Yafo, Israel, Medigus serves a global market, including the United States, Europe, Asia, and Israel. Its diverse operations span across several segments: Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others. This broad spectrum of activities underlines the company's commitment to leveraging technology in various domains, from medical devices to digital platforms and consumer products.

Products and Services

  • Medigus Ultrasonic Surgical Endostapler
  • An innovative endoscopy system intended for the treatment of gastroesophageal reflux disease (GERD). This product showcases Medigus's commitment to advancing medical procedures through technology, providing a less invasive option for patients suffering from GERD.

  • Biological Gels
  • Development of biological gels aimed at protecting individuals from biological threats. These gels are designed to minimize the entry of allergens and viruses through the upper airways and eye cavities, reflecting the company's efforts in public health and safety.

  • Digital Advertising Platform
  • A platform that facilitates digital advertising, which demonstrates Medigus's diversification into online marketing solutions. This service leverages advanced technology to optimize online advertising and Internet traffic routing, helping businesses achieve better visibility and engagement with their target audience.

  • Online Consumer Products Sales
  • Operation of online stores for the sale of a variety of consumer products through the Amazon online marketplace. This aspect of Medigus's operations represents its venture into the e-commerce space, enabling direct sales and distribution of products to consumers internationally.

  • Online Event Management and Ticketing Platform
  • The company also offers an online platform for event management and ticketing, catering to the comprehensive needs of event organizers. This service simplifies the planning, promotion, and execution of events, illustrating Medigus's capacity for digital innovation beyond its medical device core.

  • Miniaturized Imaging Equipment
  • Medigus develops, produces, and markets advanced miniaturized imaging equipment and visualization solutions. This product line is crucial for medical diagnostics and procedures, offering high-quality imaging in compact, easily maneuverable devices.

  • Electric Vehicles
  • Exploring the field of sustainable transportation, Medigus is involved in the development of electric vehicles (EVs). This initiative reflects the company's commitment to environmental sustainability and its diversification into new, high-growth areas.

  • Wireless Vehicle Battery Charging Technologies
  • Alongside EVs, Medigus is developing technologies for wireless charging of vehicle batteries. This innovation aims to enhance the convenience and efficiency of using electric vehicles, pushing forward the boundaries of what's possible in EV infrastructure technology.

Contact Information

Address: 10 Hanechoshet
Phone: 972 73 370 4691